903 results match your criteria: "UT Health Austin & Dell Children's Medical Center[Affiliation]"

Article Synopsis
  • - The neonatal Fc receptor (FcRn) plays a key role in transporting and protecting IgG antibodies, and researchers are exploring the potential of FcRn inhibitors to treat various immune-related diseases.
  • - Studies indicate that FcRn inhibitors can effectively lower total IgG levels without affecting its production or the levels of other antibody types, showing promise as a safer alternative to existing immunosuppressive therapies.
  • - More extensive clinical trials with diverse patient groups are needed to confirm the effectiveness and safety of FcRn inhibitors before they can become standard treatment options for hematologic conditions related to IgG antibodies.
View Article and Find Full Text PDF

QRS fragmentation versus QRS prolongation in predicting right ventricular enlargement and dysfunction in children and adults with repaired Tetralogy of Fallot.

Int J Cardiol Congenit Heart Dis

September 2023

Division of Pediatric Cardiology, Department of Pediatrics, Shawn Jenkins Children's Hospital, Medical University of South Carolina, 10 McClennan Banks Drive SJ2190G, Charleston, SC 29425, USA.

Patients with repaired Tetralogy of Fallot (rTOF) have risks of late life-threatening sequelae, including right ventricular (RV) dilation and failure, arrhythmias, and sudden death. QRS prolongation is a well-known ECG predictor of these outcomes but has poor sensitivity for mortality. Growing evidence demonstrates QRS fragmentation (fQRS) as a better prognostic marker for mortality in adults with rTOF, though the two markers have not been directly compared as correlates for CMR abnormalities.

View Article and Find Full Text PDF

Background: The Chronic Hypertension and Pregnancy Study demonstrated that a target blood pressure of <140/90 mm Hg during pregnancy is associated with improved perinatal outcomes. Outside of pregnancy, pharmacologic therapy for patients with diabetes and hypertension is adjusted to a target blood pressure of <130/80 mm Hg. During pregnancy, patients with both diabetes and chronic hypertension may also benefit from tighter control with a target blood pressure <130/80 mm Hg.

View Article and Find Full Text PDF

Incidence and Outcomes of Iatrogenic Complete Atrioventricular Block After Congenital Heart Surgery.

Ann Thorac Surg

September 2024

Department of Surgery and Perioperative Care, Dell Medical School at The University of Texas at Austin, Austin Texas; Texas Center for Pediatric and Congenital Heart Disease, Dell Children's Medical Center and UT Health Austin, Austin Texas.

Background: Iatrogenic complete atrioventricular block (ICAVB) has long been noted as a major complication after congenital heart surgery (CHS), and it contributes to complex postoperative care and potentially affects patients' outcomes.

Methods: This study is a retrospective review of the Pediatric Health Information System database from January 1, 2004 to September 30, 2023. All patients who underwent The Society of Thoracic Surgeons benchmark procedures were included.

View Article and Find Full Text PDF
Article Synopsis
  • * It traces the history of research from the 1990s linkage studies to current genome-wide association studies, illustrating the evolution of this scientific field.
  • * The authors emphasize the importance of ethical and scientific scrutiny in this area of research and offer recommendations to promote social and ethical responsibility in future studies.
View Article and Find Full Text PDF

Bridging clinical informatics and implementation science to improve cancer symptom management in ambulatory oncology practices: experiences from the IMPACT consortium.

JAMIA Open

October 2024

Division of Health System Innovation and Research, Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT 84132, United States.

Article Synopsis
  • The study explores the integration of clinical informatics (CI) and implementation science (IS) in improving cancer symptom management during trials, focusing on electronic patient-reported outcomes (ePROs).
  • Researchers faced challenges with electronic health records (EHRs), including limited functionality and the need for strong planning and organizational support to effectively collect and respond to patient-reported symptoms.
  • A unified understanding and shared terminology between CI and IS teams can enhance EHR design and improve the implementation of ePRO systems in oncology, leading to better monitoring and management of cancer symptoms.
View Article and Find Full Text PDF

Identifying groups at-risk to extreme heat: Intersections of age, race/ethnicity, and socioeconomic status.

Environ Int

September 2024

Department of Family and Consumer Studies, University of Utah, Salt Lake City, UT, 84112 USA. Electronic address:

Anthropogenic climate change has resulted in a significant rise in extreme heat events, exerting considerable but unequal impacts on morbidity and mortality. Numerous studies have identified inequities in heat exposure across different groups, but social identities have often been viewed in isolation from each other. Children (5 and under) and older adults (65 and older) also face elevated risks of heat-related health impacts.

View Article and Find Full Text PDF

Background: Given the risk of infection through face-touching behaviors, investigators have called for more research into the development of interventions to reduce the frequency of face-touching. The current study aims to test the effectiveness of messages on reducing face-touching behaviors.

Methods: Nine different messages that highlighted the risk of face-touching were developed.

View Article and Find Full Text PDF

Objective:  Nipocalimab is a neonatal fragment crystallizable (Fc) receptor (FcRn)-blocking monoclonal antibody that inhibits placental immunoglobulin G (IgG) transfer and lowers circulating maternal IgG levels. In an open-label, single-arm, phase 2 study, nipocalimab demonstrated evidence of safety and efficacy that support further investigation in a pivotal phase 3 trial of recurrent hemolytic disease of the fetus and newborn (HDFN). The phase 3 AZALEA study aims to evaluate the efficacy and safety of nipocalimab in a larger population at risk for severe HDFN, defined as HDFN associated with poor fetal outcomes or neonatal death.

View Article and Find Full Text PDF

Surgical management of rare tumors (Part 1).

Pediatr Blood Cancer

August 2024

Division of Pediatric Surgery, Yale School of Medicine, Yale-New Haven Hospital, New Haven, Connecticut, USA.

With an annual cumulative occurrence of approximately 15,000 in North America, all childhood cancers are rare. Very rare cancers as defined by both the European Cooperative Study Group for Rare Pediatric Cancers and the Children's Oncology Group fall into two principal categories: those so uncommon (fewer than 2 cases/million) that their study is challenging even through cooperative group efforts (e.g.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on ventilator-dependent infants and children with bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) to assess their health outcomes.
  • Approximately 60% of the 154 subjects had pulmonary hypertension, with many requiring specific medications; those with PH tended to transition to home ventilation and discharge at older ages.
  • Despite the challenges, most subjects improved over time, successfully weaning off oxygen and ventilators by age 5, with a low mortality rate after discharge.
View Article and Find Full Text PDF

This article introduces the need for creating programs to address pervasive perinatal mood and anxiety disorders (PMAD) for neonatal-intensive care unit (NICU) families. When left unrecognized and untreated, PMADs impact the outcomes of NICU families and children. There is currently no standard of care for addressing NICU PMADs.

View Article and Find Full Text PDF
Article Synopsis
  • Several European countries successfully integrated this method into their routine prenatal care, while it has recently been adopted by two U.S. companies using next-gen sequencing technology.
  • With a current shortage of RhoGAM, there’s a push to use these reliable DNA assays in the U.S. to optimize the use of Rhesus immune globulin for RhD-negative pregnant women.
View Article and Find Full Text PDF

Laboratory evolution studies have demonstrated that parallel evolutionary trajectories can lead to genetically distinct enzymes with high activity towards a non-preferred substrate. However, it is unknown whether such enzymes have convergent conformational dynamics and mechanistic features. To address this question, we use as a model the wild-type Homo sapiens kynureninase (HsKYNase), which is of great interest for cancer immunotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the link between indoor air pollution and respiratory issues in children with bronchopulmonary dysplasia (BPD) under 3 years old.
  • It involved 1,011 participants, with over 40% exposed to indoor pollutants like tobacco smoke and gas stoves, revealing higher odds of emergency visits and antibiotic use associated with secondhand smoke exposure.
  • While acute respiratory problems were related to indoor air pollution, chronic respiratory symptoms and rescue medication use showed no significant association.
View Article and Find Full Text PDF
Article Synopsis
  • Normal saline (NS) has been the standard fluid for treating diabetic ketoacidosis (DKA), but it can cause issues like hyperchloremic metabolic acidosis and worse kidney outcomes compared to balanced fluids (BF).
  • A study compared the safety and effectiveness of NS and BF in adult DKA patients over one year, assessing various recovery metrics and kidney health.
  • Results showed that patients receiving BF achieved DKA resolution faster (13 hours) than those on NS (17 hours), indicating BF may be a better option for treatment.
View Article and Find Full Text PDF

Background: Few studies have examined the menopausal transition in American Indian and Alaska Native (AI/AN) women; these reports indicate they are the most likely group to report bothersome vasomotor symptoms (VMS). Evidence demonstrates VMS may be a biomarker for chronic diseases. Thus, evidence-based interventions to improve VMS and other symptoms and health-screening rates for urban midlife AI/AN women are needed.

View Article and Find Full Text PDF

Management of Red Cell Alloimmunization in Pregnancy.

Obstet Gynecol

October 2024

Department of Women's Health, Dell Medical School, UT Health Austin, and the Comprehensive Fetal Center, Dell Children's Medical Center, Austin, Texas; and the Department of Obstetrics and Gynecology, Bridgeport Hospital/Yale University, Bridgeport, Connecticut.

Rhesus immune globulin has resulted in a marked decrease in the prevalence of RhD alloimmunization in pregnancy; however, antibody formation to other red cell antigens continues to occur. Evaluation for the presence of anti-red cell antibodies should be routinely undertaken at the first prenatal visit. If anti-red cell antibodies are detected, consideration of a consultation or referral to a maternal-fetal medicine specialist with experience in the monitoring and treatment of these patients is warranted.

View Article and Find Full Text PDF

A practical framework for Long COVID treatment in primary care.

Life Sci

October 2024

Department of Neurology, Dell Medical School, The University of Texas at Austin, 1601 Trinity St, Austin, TX 78712, USA.

Long COVID is a complex, multisystem illness with a poorly understood pathophysiology, absence of specific diagnostic tests or criteria, or evidence-based treatments. With over 200 identified symptoms and approximately 10% of COVID-19 cases resulting in Long COVID, it is a challenge to provide comprehensive treatment at a scale commensurate with the illness burden. The diverse manifestations of Long COVID, encompassing numerous medical specialties, typically place primary care providers (PCPs) at the forefront of management, navigating an evolving landscape of research and lack of evidence-based guidelines.

View Article and Find Full Text PDF

Objectives: Patients with dextro-transposition of the great arteries (d-TGA) frequently undergo balloon atrial septostomy (BAS) prior to the arterial switch operation (ASO) to promote atrial-level mixing. Balloon atrial septostomy has inherent risks as an invasive procedure and may not always be necessary. This study revisits the routine utilization of BAS prior to ASO.

View Article and Find Full Text PDF

Sacituzumab Govitecan (SG) is an antibody-drug conjugate that has demonstrated efficacy in patients with TROP-2 expressing epithelial cancers. In a xenograft model of intracranial breast cancer, SG inhibited tumor growth and increased mouse survival. We conducted a prospective window-of-opportunity trial (NCT03995706) at the University of Texas Health Science Center at San Antonio to examine the intra-tumoral concentrations and intracranial activity of SG in patients undergoing craniotomy for breast cancer with brain metastases (BCBM) or recurrent glioblastoma (rGBM).

View Article and Find Full Text PDF
Article Synopsis
  • - CASTs utilize CRISPR proteins and transposons for genetic transmission but cannot acquire new genetic information on their own.
  • - Research indicates that CASTs can appropriate existing CRISPR arrays from defense systems for horizontal gene transfer, particularly in type I-B and type V CAST sub-types.
  • - Additionally, findings reveal that type V CASTs have a unique unguided transposition ability, and understanding this can aid in improving their use for gene editing in different bacterial environments.
View Article and Find Full Text PDF

Reporting tumor genomic test results to SEER registries via linkages.

J Natl Cancer Inst Monogr

August 2024

Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Article Synopsis
  • Precision medicine is increasingly important in cancer care, but tumor genomic data has been lacking in the National Cancer Institute's SEER Program, limiting research on molecular subtypes.
  • To improve this, the SEER Program has implemented a centralized process to link cancer cases in their registries with genomic test results from molecular labs, using specialized software and a trusted third party for data handling.
  • Recent linkages have included various OncotypeDX tests and results from other genomic classifiers, which facilitate the research community's access to valuable, de-identified data for cancer studies.
View Article and Find Full Text PDF

Background: Pediatric trauma centers have had challenges meeting the American College of Surgeons criteria for screening and intervening for alcohol with adolescent trauma patients. The study objective was to conduct an implementation trial to evaluate the effectiveness of the Science to Service Laboratory (SSL) implementation strategy in improving alcohol and other drugs (AOD) screening, brief intervention, and referral to treatment (SBIRT) delivery at pediatric trauma centers.

Methods: Using a stepped wedge cross-over cluster randomized design, 10 US pediatric trauma centers received the SSL implementation strategy to deliver SBIRT with admitted adolescent (12-17 years old) trauma patients.

View Article and Find Full Text PDF